Diagnostic marker for ovarian cancer
The present invention relates to methods of detecting, monitoring the efficacy of treatment of, and assessing the severity of ovarian cancer, by assessing the concentration of haptoglobin-1 precursor in a sample of biological fluid. The invention also relates to a kit comprising an antibody or nucle...
Saved in:
Main Author | |
---|---|
Format | Patent |
Language | English |
Published |
29.11.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!